By Rick Winterson  Vertex Pharmaceuticals is a worldwide biotechnology corporation. It was founded 35 years ago in Cambridge.  It has now established its global headquarters on Fan Pier in South ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Boston Redevelopment Authority d/b/a Boston Planning & Development Agency (the “BRA”), is issuing an Invitation for Bids (“IFB”) entitled “LONG WHARF SEAWALL STABILIZATION” at 206 Atlantic Avenue, ...

Butler's Wharf Residence is now open for bookings for 2025/26. We are closely monitoring system performance however, your feedback is invaluable during this process ...

Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.72% to $416.96 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.21 ...

Vertex Pharmaceuticals' current market capitalization, exceeding $108 billion as of January 15, 2025, reflects strong investor confidence in its established cystic fibrosis (CF) franchise and its ...

It usually doesn't matter if you buy a given stock immediately or two weeks later. Sure, the stock could move up or down but typically not enough to matter all that much. However, there are ...

The most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $416.96, reflecting a -1.72% shift from the previouse trading day's closing. The stock's performance was behind ...

In a court filing on Monday, the Department of Health and Human Services fired back at Vertex Pharmaceuticals, standing by a directive that the biotech’s proposed fertility services program to go with ...

OVERLOOKING Lake Macquarie in the serene grounds of Raffertys Resort is a venue that has opened to a constant stream of keen locals, happy to finally have somewhere for a pub lunch and a waterfront ...

Shares of Vertex Pharmaceuticals Inc. VRTX advanced 3.06% to $424.26 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising ...

Vertex Pharmaceuticals (VRTX) comes in second with a score of 4.04 and a Buy rating given its dominance in the cystic fibrosis treatment category and diversified pipeline, making a compelling case ...